| Autor: |
Tamura T; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Sugihara Y; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Yamazaki H; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Koutani H; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Tamura T; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Tsuda I; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Emori T; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Kawaji Y; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Hatamaru K; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Yamashita Y; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Itonaga M; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Ashida R; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan., Kitano M; Second Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan. |
| Abstrakt: |
The purpose of this study is to clarify the associations between the enhancement patterns on contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) and the aggressiveness and prognosis of pancreatic neuroendocrine neoplasms (PanNENs). Patients who underwent CH-EUS and were pathologically diagnosed with PanNEN were included in this study. Patients were divided into three groups according to contrast-enhancement patterns on early-phase and late-phase imaging: “Group A”, vascular rich in both phases; “Group B”, vascular rich and vascular poor in early and late phases, respectively; “Group C”, vascular poor in both phases. Of 39 patients, 25 were assigned to Group A, 7 to Group B, and 7 to Group C. The median overall survival was not reached in Groups A and B and was 335 days in Group C (p < 0.001). The 1-year survival rates were 100% in Group A, 60% in Group B, and 43% in Group C. Patients in Group C showed the shortest overall survival among the three groups. The vascular-poor pattern on late-phase CH-EUS had the highest sensitivity, specificity, and accuracy for aggressive PanNENs among the patterns analyzed on CH-EUS and CECT (84.6%, 91.7%, and 89.2%, respectively). CH-EUS is useful for the diagnosis of and predicting the prognosis of PanNENs. |
